Literature DB >> 15291740

Thyroid hormone regulation of prohormone convertase 1 (PC1): regional expression in rat brain and in vitro characterization of negative thyroid hormone response elements.

X Shen1, Q-L Li, G A Brent, T C Friedman.   

Abstract

Most pro-neuropeptides are processed by the prohormone convertases, PC1 and PC2. We previously reported that changes in thyroid status altered anterior pituitary PC1 mRNA and this regulation was due to triiodothyronine (T(3))-dependent interaction of thyroid hormone receptor (TR) with negative thyroid hormone response elements (nTREs) contained in a large region of the human PC1 promoter. In this study, we demonstrated that hypothyroidism stimulated, while hyperthyroidism suppressed, PC1 mRNA levels in rat hypothalamus and cerebral cortex, but not in hippocampus. In situ hybridization was used to confirm real-time PCR changes and localize the regulation within the hypothalamus and cortex. Using a human PC1 (hPC1) promoter construct (with and without deletions in two regions that each contain a negative TRE) transiently transfected into GH3 cells, we found that T(3) negatively regulated hPC1 promoter activity, and this regulation required both of these two regions. Electrophoretic mobility shift assays (EMSAs) using purified thyroid hormone receptor alpha1 (TRalpha1) and retinoid X receptor beta (RXRbeta) proteins demonstrated that RXR and TRalpha both bound the PC1 promoter. Addition of TRalpha1/RXRbeta to the wild-type PC1 probe demonstrated binding as both homodimers and a heterodimer. EMSAs with oligonucleotides containing deletion mutations of the putative nTREs demonstrated that the proximal nTRE binds more strongly to TR and RXR than the distal nTRE, but that both regions exhibit specific binding. We conclude that there are multiple novel TRE-like sequences in the hPC1 promoter and that these regions act in a unique manner to facilitate the negative effect of thyroid hormone on PC1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15291740     DOI: 10.1677/jme.0.0330021

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  5 in total

1.  Repression of cardiac phospholamban gene expression is mediated by thyroid hormone receptor-{alpha}1 and involves targeted covalent histone modifications.

Authors:  Madesh Belakavadi; Jason Saunders; Noah Weisleder; Preethi S Raghava; Joseph D Fondell
Journal:  Endocrinology       Date:  2010-04-14       Impact factor: 4.736

Review 2.  Regulation of the hypothalamic thyrotropin releasing hormone (TRH) neuron by neuronal and peripheral inputs.

Authors:  Eduardo A Nillni
Journal:  Front Neuroendocrinol       Date:  2010-01-13       Impact factor: 8.606

3.  Morphine treatment selectively regulates expression of rat pituitary POMC and the prohormone convertases PC1/3 and PC2.

Authors:  Ying Nie; Monica G Ferrini; Yanjun Liu; Adrian Anghel; Enma V Paez Espinosa; Ronald C Stuart; Kabirullah Lutfy; Eduardo A Nillni; Theodore C Friedman
Journal:  Peptides       Date:  2013-07-26       Impact factor: 3.750

4.  Genetics of the first seven proprotein convertase enzymes in health and disease.

Authors:  Hannu Turpeinen; Zsuzsanna Ortutay; Marko Pesu
Journal:  Curr Genomics       Date:  2013-11       Impact factor: 2.236

5.  Functional and clinical relevance of novel and known PCSK1 variants for childhood obesity and glucose metabolism.

Authors:  Dennis Löffler; Susanne Behrendt; John W M Creemers; Jürgen Klammt; Gabriela Aust; Juraj Stanik; Wieland Kiess; Peter Kovacs; Antje Körner
Journal:  Mol Metab       Date:  2016-12-08       Impact factor: 7.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.